Pharmaceuticals
Govt invokes special powers to ensure steady supply of coronary stents
22 Feb 2017
Manufacturers have been ordered to submit a weekly report on coronary stents produced and distributed besides a weekly production plan to the drug pricing authority
Authorities crack down on stent ‘hoarders’ after price caps
17 Feb 2017
The government will use various provisions of the Essential Commodities Act to penalise those found illegally and unethically profiteering or hoarding stents
India slashes stent prices by up to 85%; cap at Rs30,000
14 Feb 2017
In a major relief for heart patients, the National Pharmaceutical Pricing Authority has fixed the ceiling price of drug eluting stents (DES) and bioresorbable stents at Rs30,000 and of bare metal stents at Rs7,500
.webp)
